The QualityStocks Daily Thursday, October 10th, 2024

Today's Top 3 Investment Newsletters

360 Wall Street(BLMZ) $1.3400 +87.36%

QualityStocks(MLGO) $0.3746 +48.65%

Trading Tips(SRFM) $3.2700 +40.34%

The QualityStocks Daily Stock List

MicroAlgo Inc. (MLGO)

Premium Stock Alerts, QualityStocks, MarketClub Analysis, Timothy Sykes, InvestorsUnderground, Tim Bohen, INO Market Report, 360 Wall Street, The Stock Dork, stockstotrade, Money Wealth Matters, Investors Underground and Broad Street reported earlier on MicroAlgo Inc. (MLGO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

MicroAlgo Inc. (NASDAQ: MLGO) is an information technology firm that is focused on the development and delivery of central processing algorithm solutions to consumers in internet advertisement, gaming and intelligent chip industries.

The firm has its headquarters in Shenzhen, China. Prior to its name change, the firm was a holding company known as Venus Acquisition Corp. It operates as part of the software-infrastructure industry, under the technology sector. The firm serves consumers around the globe, with a focus on those in the People’s Republic of China.

The company operates through two segments, Central Processing Algorithm Services, and Intelligent Chips and Services. It provides comprehensive solutions to customers by integrating central processing algorithms with software or hardware, or both, thereby helping them to increase the number of customers, improve end-user satisfaction, achieve direct cost savings, reduce power consumption, and achieve technical goals. The company operates as a subsidiary of WiMi Hologram Cloud Inc.

The enterprise’s service offerings include algorithm optimization, accelerating computing power without the need for hardware upgrades, data processing, and data intelligence services. It also engages in the resale of intelligent chips and accessories; and provision of software development.

The firm, which recently appointed its first brand ambassador to help create an intersection between art and hospitality that offers its guests memorable experiences, is focused on elevating its industry profile and expanding its portfolio. This will help extend its consumer reach and open the firm up to new growth and investment opportunities.

MicroAlgo Inc. (MLGO), closed Thursday's trading session at $0.3746, up 48.6508%, on 203,795,363 volume. The average volume for the last 3 months is 12.68M and the stock's 52-week low/high is $0.1904/$155.999.

CN Energy Group (CNEY)

QualityStocks, MarketClub Analysis, Premium Stock Alerts, Money Wealth Matters, InvestorPlace and 360 Wall Street reported earlier on CN Energy Group (CNEY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CN Energy Group Inc. (NASDAQ: CNEY) is a holding firm that is focused on the manufacture and supply of wood-based activated carbon.

The firm has its headquarters in Lishui, the People’s Republic of China and was incorporated in 2018, on November 23rd. It has also established well-developed sales networks and offices in Manzhouli, Tahe, Harbin and Hangzhou. The firm mainly serves consumers in China.

The company specializes in the co-generation of high-quality wood-activated carbon, heat and clean energy. It mainly operates on the development principles of the renewable energy industry and the principles of the green, circular economy.

The enterprise manufactures activated carbon products which are classified into 6 categories, namely medicinal activated carbon, doxycycline special activated carbon, chemical reagent type activated carbon, food additive activated carbon, chemical decolorization activated carbon and environmentally friendly activated carbon. These activated carbon products possess strong chemical and physical adsorption ability, which is why they’re widely used in food and beverage production, environmental protection, water purification, industrial manufacturing and pharmaceutical manufacturing. It is also engaged in the production and supply of biomass electricity which is generated in the process of activated carbon production, to State Grid Heilongjiang Electric Power Company Ltd.

The firm plans to expand into the multi-billion-dollar water purification market, which is forecasted to grow at a CAGR of 7.2% in the period between 2021-2028, to reach $47 billion. This move will create significant new profit and revenue opportunities as well as boost the company’s growth. This is in addition bringing in more investors into the firm.

CN Energy Group (CNEY), closed Thursday's trading session at $0.71, up 34.7763%, on 27,042,779 volume. The average volume for the last 3 months is 56,276 and the stock's 52-week low/high is $0.2547/$4.05.

Innovate Corp. (VATE)

QualityStocks, CFN Media Group, The Online Investor, Penny Picks, MarketClub Analysis, FreeRealTime and Damn Good Penny Picks reported earlier on Innovate Corp. (VATE), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Innovate Corp (NYSE: VATE) (FRA: PST) is an investment holding firm that focuses and operates in the life sciences, infrastructure and spectrum areas.

The firm has its headquarters in New York, the United States and was incorporated in 1994. Prior to its name change in September 2021, the firm was known as HC2 Holdings Inc. It operates as part of the engineering and construction industry, under the industrials sector. The firm serves consumers across the globe.

The enterprise operates through the Spectrum, Life Sciences, Insurance, Telecommunications, Clean Energy, Infrastructure and Other segments. The Spectrum segment is focused on owning Spanish-language broadcast network and over-the-air broadcasting stations while the Life Sciences segment maintains controlling interests in R2 Tech Inc. and Genovel Orthopedics Inc. and Pansend Life Sciences LLC. The Insurance segment provides long-term care, annuity, life and other accident and health coverage while the Telecommunications segment is focused on providing voice communication services and managing telecommunications businesses, which include a network of direct routes. On the other hand, the Clean Energy segment is focused on designing, building and maintaining compressed natural gas fueling stations for transport vehicles while the Infrastructure segment is engaged in modeling, detailing, fabrication and the erection of structural steel for industrial and commercial construction projects. The Other segment represents all other investments and businesses which don’t meet a segment’s definition in the aggregate or individually.

Innovate Corp. (VATE), closed Thursday's trading session at $4.86, up 24.2967%, on 101,412 volume. The average volume for the last 3 months is 285,439 and the stock's 52-week low/high is $3.25/$15.60.

Netlist, Inc. (NLST)

Greenbackers, QualityStocks, OTCPicks, StreetInsider, HotOTC, CoolPennyStocks, StockEgg, BullRally, PennyTrader Publisher, MarketBeat, StockRich, PennyStockVille, PennyInvest, MarketClub Analysis, MadPennyStocks, CRWEWallStreet, Stock Rich, Wall Street Resources, TopPennyStockMovers, Marketbeat.com, MicrocapVoice, Momentum Traders, Stock Traders Chat, StockMarketWatch, StockOodles, The Street, BUYINS.NET, TradersPro, Trading Concepts, Wyatt Investment Research, DrStockPick, Penny Sleuth, CRWEPicks, CRWEFinance, BestOtc, Penny Invest, SmallCapNetwork, AllPennyStocks, PennyOmega, StockHotTips, PennyToBuck, PennyTrader, Penny Stock Rumble, Stockpalooza, Dividend Opportunities, StockMister, The Momentum Traders Network, Top Stock Picks, Dynamic Wealth Report, TradingMarkets, INO Market Report, Wise Alerts, Barchart, Alternative Energy, TopStockAnalysts, Stock Fortune Teller, PennyStocks24, SmarTrend Newsletters, InvestorGuide, Investors Alley, SmallCapVoice, SmallCapReview, PoliticsAndMyPortfolio, MarketWatch, MicroCapINPLAY, Momentum Trades, Zacks and Hit and Run Candle Sticks reported earlier on Netlist, Inc. (NLST), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Netlist, Inc. (OTCQB: NLST) (LON: 0K6M) is a company focused on designing, manufacturing and marketing memory subsystems for the serve, high-performance computing and communications markets.

The firm has its headquarters in Irvine, California and was incorporated in June 2000 by Christopher Lopes, Chun Ki Hong and Jayesh Bhakta. It operates as part of the tech hardware and semiconductors industry, under the semiconductors industry, in the technology sector. The firm serves consumers around the globe, with a focus on those in the United States.

The enterprise’s offerings include a storage-class memory product known as HybriDIMM, which unifies dynamic random-access memory (DRAM) and NAND flash in a plug-and-play module delivering terabyte storage capacities operating at nanosecond memory speeds. It also offers nonvolatile (NV) memory products, such as NVvault DDR4 NVDIMM that provides data acceleration and protection in a joint electron device engineering council standard DDR4 interface; and specialty DIMMs and embedded flash products for use in data center and industrial applications. It resells component products, including DRAM, solid state drive (SSDs) and NAND flash products to storage customers, appliance customers, system builders, and cloud and data center customers. This is in addition to selling component inventory to distributors and other users of memory integrated circuits. The enterprise markets and sells its products through a direct sales force and a network of independent sales representatives.

Netlist, Inc. (NLST), closed Thursday's trading session at $1.38, up 16.7513%, on 908,517 volume. The average volume for the last 3 months is 275,598 and the stock's 52-week low/high is $1.00/$2.97.

Root Inc. (ROOT)

StockEarnings, StocksEarning, Schaeffer's, MarketBeat, QualityStocks, TradersPro, Zacks, InvestorPlace, Cabot Wealth, The Street, StreetInsider, MarketClub Analysis, INO Market Report and Early Bird reported earlier on Root Inc. (ROOT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Root Inc. (NASDAQ: ROOT) is a holding firm that is engaged in the provision of insurance services.

The firm has its headquarters in Columbus, Ohio and was incorporated in 2015. It operates as part of the insurance carriers’ industry and has two companies in its corporate family. The firm serves consumers in the United States.

The company is a direct-to-consumer personal auto insurance, mobile technology and renters’ insurance firm which operates through its direct-to-consumer insurance products segment. It has the infrastructure to design products as well as underwrite, administer and pay claims on all of its policies. The company generates most of its revenue from the sale of auto insurance policies in the U.S. It mainly serves consumers via mobile apps and its distribution partners, as well as via its website. Its distribution channels also cover referral, media and digital channels. The company’s mobile platform allows consumers to manage policy adjustments as well as adjudicate claims digitally.

The enterprise collects and synthesizes sensory behavioral data across different variables and bases its pricing for policies more on causality than correlation. It provides renters insurance, home owners and auto products as well as creative, change management and employee engagement solutions.

The company recently appointed a new Chief Revenue and Operating Officer whose objective will be to streamline operations within the business and drive its revenue. This is in addition to overseeing performance in growth and marketing, which will be instrumental in driving the company’s growth and attracting investments into the firm and may also have a positive influence on its success.

Root Inc. (ROOT), closed Thursday's trading session at $44.5, up 16.4921%, on 722,003 volume. The average volume for the last 3 months is 17,375 and the stock's 52-week low/high is $7.22/$86.57.

Avalo Therapeutics (AVTX)

QualityStocks, Zacks, Early Bird, MarketBeat and Timothy Sykes reported earlier on Avalo Therapeutics (AVTX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Avalo Therapeutics Inc. (NASDAQ: AVTX) (FRA: C6K0) is a clinical stage medicine firm that is focused on discovering, developing and commercializing therapeutics for patients with unmet clinical needs in rare genetic, immune-oncology and immunology illnesses.

The firm has its headquarters in Rockville, Maryland and was incorporated in 2011, on January 31st by Solomon H. Snyder, Barbara S. Slusher, Isaac Blech and Blake M. Paterson. Prior to its name change in August 2021, the firm was known as Cerecor Inc. It operates as part of the scientific research and development services industry and serves consumers around the world.

The company uses a precision medicine approach to develop and commercialize highly targeted therapeutics. It operates a bioassay facility in Germantown.

The enterprise’s product pipeline is made up of an anti-light mAb dubbed AVTX-002, which targets immune-inflammatory ailments like moderate-to-severe inflammatory bowel disease and acute respiratory distress syndrome. It also offers an anti-IL-18 mAb, which targets immune-inflammatory and immune-oncology illnesses like Still’s disease and multiple myeloma. Still’s disease is a disorder that’s characterized by arthritis, a rash, high spiking fevers and inflammation. In addition to this, the enterprise also develops AVTX-801, AVTX-802 and AVTX-803, which are therapeutic monosaccharide therapy doses indicated for congenital disorders of glycosylation; and a dual mTORc1/c2 inhibitor dubbed AVTX-006, which targets lymphatic malformations.

Avalo Therapeutics (AVTX), closed Thursday's trading session at $10.13, up 12.1816%, on 20,414 volume. The average volume for the last 3 months is 1.483M and the stock's 52-week low/high is $3.9501/$45.096.

Vivid Seats Inc. (SEAT)

MarketBeat, Zacks, Trades Of The Day, StockEarnings, Schaeffer's, InvestorPlace and Daily Trade Alert reported earlier on Vivid Seats Inc. (SEAT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Vivid Seats Inc. (NASDAQ: SEAT) (NASDAQ: SEATW) is an online ticket marketplace which allows fans and event seekers to purchase tickets for sports, concerts, theater, and other live events.

The firm has its headquarters in Chicago, Illinois and was incorporated in 2001. It operates as part of the internet content and information industry, under the communication services sector. The firm serves consumers in the United States.

Vivid Seats Inc. operates through the Marketplace and Resale segments. The Marketplace segment acts as an intermediary between event ticket buyers and sellers; and processes ticket sales on its website and mobile applications through its distribution partners. It also sells tickets for sports, concerts, theater events, and other live events. In addition to this, the segment offers Vivid Picks daily fantasy sports, which allows users to partake in contests by making picks from various sport and player matchups; and Skybox, a proprietary enterprise resource planning tool that helps ticket sellers manage ticket inventories, adjust pricing, and fulfill orders across multiple ticket resale marketplaces. On the other hand, the Resale segment acquires tickets to resell on secondary ticket marketplaces. It also offers internal research and development support for Skybox delivers seller software and tools.

The company recently announced an exclusive, multiyear media deal with I Am Athlete, an athlete-led media platform founded by former NFL All-Pro receiver, Brandon Marshall. The new strategic partnership includes exclusive content featuring athletes and celebrities, advertising and sponsorship rights, and live event experiences. This affords the company a new way for it to engage with fans and meet the growing consumer demand for best-in-class and compelling content. The company remains focused on brand affinity and expanding its engagement strategies, a move that’ll encourage additional investments into the company.

Vivid Seats Inc. (SEAT), closed Thursday's trading session at $3.77, up 0.802139%, on 811,224 volume. The average volume for the last 3 months is 18.552M and the stock's 52-week low/high is $3.36/$8.8028.

Alibaba Group Holding Ltd. (BABA)

InvestorPlace, The Street, Kiplinger Today, Schaeffer's, MarketClub Analysis, Zacks, Money Morning, StreetInsider, Trades Of The Day, Daily Trade Alert, Marketbeat, Market Intelligence Center Alert, StocksEarning, Investopedia, The Online Investor, Wealth Insider Alert, StreetAuthority Daily, Early Bird, ProfitableTrading, CustomerService, Marketbeat.com, TopStockAnalysts, QualityStocks, Louis Navellier, Uncommon Wisdom, GorillaTrades, Top Pros' Top Picks, TipRanks, StockEarnings, Cabot Wealth, CNBC Breaking News, AllPennyStocks, Profit Confidential, The Wealth Report, Options Elite, Investors Alley, Total Wealth, Street Insider, Money and Markets, INO.com Market Report, Daily Profit, Barchart, The Street Report, Wyatt Investment Research, SmallCapVoice, Investing Daily, StrategicTechInvestor, Market Intelligence Center, Insider Wealth Alert, Average Joe Options, Power Profit Trades, Daily Wealth, Trade of the Week, FreeRealTime, Investing Signal, MarketTamer, INO Market Report, Wealth Daily, WStreet Market Commentary, Trader Prep, BUYINS.NET, Wall Street Daily, Trading Concepts, MarketWatch, Short Term Wealth, The Best Newsletters, Investors Underground, InvestmentHouse, Earnings360, Visual Capitalist, Inside Investing Daily, 24/7 Trader, TheOptionSpecialist, StockReport, ChineseWire, Rick Saddler, Dynamic Wealth Report, The Weekly Options Trader, Energy and Capital, Daily Dividends, Investing Lab, Investment U, Agora Financial, OptionAlarm News, MarketArmor.com, InvestorsHQ, Wealthpire Inc., SureMoney, Investing Futures, Eagle Financial Publications, Weekly Wizards, DividendStocks, Dividend Opportunities, Direction Alerts, wyatt research newsletter, MarketDeal, wealthmintrplus, Navellier Growth, StockMarketWatch, Outsider Club, BillionDollarClub, Beat The Street, Stock Gumshoe, SmallCapNetwork, Atomic Pennies, Profits Run, Rockwell Trading, 24-7 Stock Alert, TheoTrade, Jim Cramer, Investor Guide, The Growth Stock Wire, Terry's Tips, Investment House, Investiv, Shah's Insights & Indictments, InvestorsObserver Team, Market Authority, The Night Owl, InsiderTrades, Summa Money, Inside Trading, Energy & Resources Digest, Wallstreet Journal, Kiplinger’s Weekly Update, Hit and Run Candle Sticks, Greenbackers, The Trading Report, Goldman Small Cap Research, Liberty Through Wealth, Financial Freedom Post, Equities.com, InvestorGuide and The Stock Dork reported earlier on Alibaba Group Holding Ltd. (BABA), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Investment banking firm Jefferies Group has increased its stock rating for Chinese e-commerce giant Alibaba Group Holding Ltd. (NYSE: BABA) from $116 to $142 and maintained a Buy rating for Alibaba’s shares. According to Jefferies’ analysis, Alibaba and other players in the e-commerce industry are often subject to critical events that shift how valuation is approached, and this results in re-evaluations. As such, recently passed policies signal the potential for recovery for the e-commerce industry after several months of poor performance.

Jefferies’ new stock valuation for Alibaba was based on projections for next year. The Chinese company has become a major player in the online trade market through its various subsidiaries and is now competing with leading e-commerce companies, including Amazon. Alibaba’s extended forays into the technology space have made it one of the top cloud-storage providers on the globe, and it is now using generative artificial intelligence (AI) to improve its cloud-service delivery.

Jefferies identified Alibaba as one of several companies that were “potentially undervalued,” especially when compared to its overseas competitors. However, the banking investment company leverages forward-looking strategies when it values companies, and this provided it with a better outlook of Alibaba’s financial performance in the future.

The decision to raise Alibaba’s stock rating to $142 indicates Jefferies’ increased conviction in the future growth prospects of Alibaba as it came from the investment banking company’s analysis of the e-commerce industry and how Alibaba has positioned itself within the sector. With a total reported revenue of RMB 243 billion ($34.6 billion), Alibaba fell just short of reaching the RMB 250 billion ($35.6 billion) market consensus but still surpassed gross profit projections by RMB 97.1 billion ($13.8 billion).

This resulted in analysts from companies such as Jefferies, Truist Securities, JPMorgan, Bernstein SocGen Group, Baird and Susquehanna adjusting their price targets for the Chinese e-commerce giant. JPMorgan kept an Overweight rating for Alibaba as it expects improvements in gross merchandise volume, traffic and the monetization of critical Alibaba platforms Tmall and Taobao.

Jefferies, on the other hand, acknowledged that Alibaba had successfully completed a three-year rectification process recognized by the Chinese State Administration for Market Regulation and maintained its Buy rating.

This is good news for Alibaba as the company recently unveiled an artificial intelligence-powered sourcing agent as well as new logistics and financial solutions to increase efficiency for small and medium-sized companies. In the meantime, experts expect Alibaba Cloud’s external customer growth to hit double digits in the fiscal year’s second half as Alibaba Group’s loss-making enterprises hit its break-even point in the next year or two.

Alibaba Group Holding Ltd. (BABA), closed Thursday's trading session at $109.28, up 1.2883%, on 19,736,630 volume. The average volume for the last 3 months is 538,510 and the stock's 52-week low/high is $66.63/$117.82.

Sprout Social (SPT)

MarketBeat, Kiplinger Today, InvestorPlace, StreetInsider, MarketClub Analysis, QualityStocks, Schaeffer's, Trades Of The Day, Penny Stock 101, OTC Stock Review, Wealth Insider Alert, BUYINS.NET, TradersPro, FreeRealTime, Early Bird, Daily Trade Alert, Cabot Wealth and Marketbeat.com reported earlier on Sprout Social (SPT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Sprout Social (NASDAQ: SPT), a leader in cloud-based social media management software, will announce its financial results for the third quarter ending Sept. 30, 2024, after market close on Thursday, Nov. 7, 2024. The company will host a conference call and webcast at 4:00 p.m. CT (5:00 p.m. ET) on the same day to discuss the results and business highlights. Interested parties can register for the event and access the live webcast through Sprout Social’s investor relations website, where a replay will remain available for 12 months.

To view the full press release, visit https://ibn.fm/9i3bO

About Sprout Social Inc.

Sprout Social is a global leader in social media management and analytics software. Sprout’s intuitive platform puts powerful social data into the hands of more than 30,000 brands so they can deliver smarter, faster business impact. Named the #1 Best Software Product by G2’s 2024 Best Software Award, Sprout offers comprehensive publishing and engagement functionality, customer care, influencer marketing, advocacy, and AI-powered business intelligence. Sprout’s software operates across all major social media networks and digital platforms. For more information, visit the company’s website at www.SproutSocial.com.

Sprout Social (SPT), closed Thursday's trading session at $28.3, off by 0.3521127%, on 586,343 volume. The average volume for the last 3 months is 2.08M and the stock's 52-week low/high is $25.0533/$68.4099.

SNDL Inc. (SNDL)

StockEarnings, Schaeffer's, InvestorPlace, QualityStocks, StocksEarning, MarketBeat, Trades Of The Day, BUYINS.NET, Daily Trade Alert, The Street, Kiplinger Today, CannabisNewsWire, StreetInsider, The Online Investor, FreeRealTime, Early Bird, TheoTrade, Prism MarketView, CNBC Breaking News, Investopedia, MarketClub Analysis, StockMarketWatch and MarketClub reported earlier on SNDL Inc. (SNDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

California Governor Gavin Newsom approved a measure that will allow the operation of marijuana cafés, modeled after those in the Netherlands. The law is set to come into effect on Jan. 1, 2025, subject to local government approvals.

Last year, Governor Newsom vetoed a similar proposal from Assembly Member Matt Haney, which would have permitted California’s cannabis retailers to run full kitchens and host events. Newsom’s main concern at the time was the lack of adequate worker protections in the bill.

In his latest signing statement, he expressed support for Haney’s improvements to the current bill. These changes include protecting employees’ right to wear masks, with employers covering the costs, and requiring that workers be informed about the dangers of secondhand marijuana smoke. Newsom also stressed that businesses that fail to follow these safeguards will not be viewed favorably.

The marijuana café law might be the only reprieve for California’s cannabis industry for the time being. The governor’s proposed $291 billion budget for FY 2024–2025 doesn’t include any cuts to the fees or taxes imposed on cannabis businesses.

Just a day earlier, Newsom vetoed a bill, AB 1111, that sought to allow small cannabis producers to sell their products directly to users, citing concerns about its wide scope. Further, he stated that the measure’s eligibility criteria, which included most licensed cannabis growers, could potentially strain the state’s cannabis control department’s regulatory efforts and disrupt the existing retail licensing structure.

The veto has been met with disappointment from advocates within the cannabis industry, particularly those representing small growers. The Origins Council, which represents around 800 producers in the Emerald Triangle, voiced its frustration, noting that small businesses are essential to the sustainability and equity of California’s cannabis market.

The bill, had it been signed into law, would have permitted small farmers to sell up to $175,000 worth of cannabis products at approved events, starting in January 2026.

Over the past few weeks, marijuana industry groups and advocates, such as the Origins Council, Equity Trade Network and Supernova Women, pushed hard for Newsom’s approval through various campaigns.

Despite the veto, Newsom noted that he was open to considering a revised version of the bill next year that would be more narrowly focused. He underlined that future legislation should address the major issues that the cannabis sector is currently facing, such as increased access to legal cannabis products and competition from unregulated sources.

This authorization of cannabis cafes in California is likely to be followed by marijuana companies, including SNDL Inc. (NASDAQ: SNDL), because it could usher in a new dynamic within legal marijuana markets in different jurisdictions. This is because when California leads the way, other jurisdictions often take a leaf from what has worked in the Golden State.

SNDL Inc. (SNDL), closed Thursday's trading session at $1.92, off by 1.5385%, on 1,225,614 volume. The average volume for the last 3 months is 593,032 and the stock's 52-week low/high is $1.30/$2.93.

atai Life Sciences N.V. (ATAI)

QualityStocks, MarketBeat, The Online Investor, PsychedelicNewsWire, StockMarketWatch, Dynamic Wealth Report, StreetInsider, MarketClub Analysis, Small Caps, Uncommon Wisdom, Marketbeat.com, CRWEWallStreet, CRWEPicks, InsiderTrades, CRWEFinance, BestOtc, DrStockPick, PennyOmega, PennyToBuck, Schaeffer's, StockHotTips, TraderPower, Awareness Stocks, StockOodles, StocksEarning, Street Insider, The Street, TopPennyStockMovers, Broad Street and ProTrader reported earlier on atai Life Sciences N.V. (ATAI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Activists in Portland recently revealed that they were working to place a measure to decriminalize psychedelics on the 2026 ballot. The measure in question, called the Portland Psychedelic Health Act, would make the enforcement of laws against specific fungi and plant-based substances, including ayahuasca, psilocybin, DMT and mescaline, a low-enforcement priority in the city.

It would also advocate for the decriminalization of psychedelics at the local level while also covering the possession, gifting and cultivation of natural psychedelics. In addition, the measure would establish an advisory panel focused on issuing guidance related to entheogens to the city.

According to the description given on the measure, it has been designed to increase education, safety and best practices in the city and state. The measure also recognizes that individuals in the city have consumed natural psychedelics for spiritual, health and personal reasons for a while and will continue to do so. It should be noted that the measure wouldn’t apply to peyote because it is an ecologically threatened species.

The campaign’s lead organizer, Nate Howard, explained that the proposal had been shaped by hundreds of stakeholders, most of whom were local, as well as individuals in the country and other parts of the globe. Organizers of the new ballot proposal are set to officially present the full text of the initiative to the public at a symposium this coming weekend.

The final version of the initiative will be submitted to officials later this month.

Signature collection to quality the initiative for the ballot will begin in early 2025, with the campaign revealing that about 40,000 valid signatures of voters would be needed for the proposal to qualify for the 2026 ballot.

The initiative would also establish a psychedelics advisory commission, a body centered on advising the city on harm reduction, responsible and safe practices, public education and the integration of psychedelics into public health initiatives.

This effort, led by the state’s Psychedelics Society Action Fund, follows past campaigns for reforms around psychedelics. This includes a 2021 push by the Plant Medicine Healing Alliance, which lobbied for the decriminalization of the ceremonial use, gifting and growing of different psychedelics. The proposal was focused on ensuring ceremonies involving entheogens and gifting of psychedelics such as ibogaine and ayahuasca were among the lowest priorities for enforcement in the state.

More broadly, the state of Oregon recently reinstated regulations against the simple possession of drugs. This is part of a process to repeal some elements of Measure 110, which legalized the possession of small drug amounts.

As more members of the public in the United States and elsewhere learn about the potential of hallucinogens, the R&D work being done by enterprises such as atai Life Sciences N.V. (NASDAQ: ATAI) could trigger even broader grassroots movements focused on championing reforms to drug laws in light of the new information available about these drugs.

atai Life Sciences N.V. (ATAI), closed Thursday's trading session at $1.08, off by 0.9174312%, on 585,963 volume. The average volume for the last 3 months is 290,117 and the stock's 52-week low/high is $1.025/$2.85.

La Rosa Holdings Corp. (LRHC)

MarketClub Analysis, StockWireNews, SmallCapStox, Small Cap Firm, QualityStocks, Premium Stock Alerts, PennyStockProphet, Investors Underground, Fierce Analyst, bullseyeoptiontrading, Broad Street and Awareness Stocks reported earlier on La Rosa Holdings Corp. (LRHC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

La Rosa Holdings Corp. (NASDAQ: LRHC) has launched My Agent Account version 3.0, a major update to its proprietary real estate platform, featuring a new module for property management disbursements. This enhancement is expected to improve operational efficiency for La Rosa's agents, who have increasingly relied on the platform. With usage up 19% year-over-year and the AI assistant JAEME playing a key role in daily operations, the company anticipates a 50% boost in agent productivity by year-end. Looking forward, version 4.0 is scheduled for release in 2025, promising further advancements.

To view the full press release, visit https://ibn.fm/Ffvsn

About La Rosa Holdings Corp.

La Rosa Holdings Corp. is disrupting the real estate industry by offering agents a choice between a revenue share model or an annual fee-based model with 100% agent commissions. Leveraging its proprietary technology platform, La Rosa empowers agents and franchisees to deliver top-tier service to their clients. The Company provides both residential and commercial real estate brokerage services and offers technology-based products and services to its sales agents and franchise agents.

La Rosa's business model is structured around internal services for agents and external services for the public, including residential and commercial real estate brokerage, franchising, real estate brokerage education and coaching, and property management. The Company has 24 La Rosa Realty corporate real estate brokerage offices and branches located in Florida, California, Texas, Georgia, and Puerto Rico. The Company also has 13 La Rosa Realty franchised real estate brokerage offices and branches and two affiliated real estate brokerage offices in the United States and Puerto Rico.

For more information, visit the company’s website at www.LaRosaHoldings.com

La Rosa Holdings Corp. (LRHC), closed Thursday's trading session at $0.57, even for the day, on 17,202 volume. The average volume for the last 3 months is 235,827 and the stock's 52-week low/high is $0.5231/$5.53.

The QualityStocks Company Corner

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom Ltd. (NASDAQ: SPCB), a global provider of secure solutions for the e-Government, IoT, and cybersecurity sectors, and its prime partner Electra, a security services provider in Israel, have been awarded a 5-year contract by the Israel Prison Service state agency ("IPS"). The full-service contract, which is already in effect and includes an optional extension of up to four more years, mandates SuperCom to deploy its PureSecurity Electronic Monitoring ("EM") Suite, namely PureCom, PureTrack, PureTag, and PureBeacon. The contract encompasses all EM offender programs within Israel, including the existing Home Detention Monitoring program and additional GPS Tracking programs, and is expected to have about 1,500 enrollees, with the potential for future expansion.

"We are deeply honored to support Israel's public safety infrastructure during these challenging times," stated Ordan Trabelsi, President and CEO of SuperCom. "Our mission goes beyond business; it is about contributing to the safety and resilience of Israel. By providing the Israel Prison Service state agency with our advanced electronic monitoring solutions, we reaffirm our unwavering commitment to making Israel safer for all its citizens."

To view the full press release, visit https://ibn.fm/Owy2t

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Thursday's trading session at $3.92, up 10.1124%, on 179,459 volume. The average volume for the last 3 months is 345,495 and the stock's 52-week low/high is $2.55/$22.60.

Recent News

Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG)

The QualityStocks Daily Newsletter would like to spotlight Platinum Group Metals Ltd. (TSX: PTM) (NYSE American: PLG).

Platinum Group Metals(TSX: PTM) (NYSE American: PLG), operator of the Waterberg Project, a bulk underground platinum group metals ("PGM") deposit located on the northern limb of the Bushveld Complex in South Africa, has filed a Definitive Feasibility Study ("DFS") technical report on its Waterberg Project, in compliance with National Instrument 43-101 Standards of Disclosure for Mineral Projects ("NI 43-101"). The study is associated with the Independent Definitive Feasibility Study, which it filed last month. Titled "Waterberg Definitive Feasibility Study Update, Bushveld Igneous Complex, Republic of South Africa," the report was prepared by a team of specialists and supports the disclosure of an updated independent mineral resource estimate, effective Aug. 31, 2024.

To view the full report, visit https://ibn.fm/9b7wz

To view the full press release, visit https://ibn.fm/Ceuja

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (PGM) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. The Waterberg Project is planned as a fully mechanised platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and is projected to be one of the largest and lowest cost PGM mines globally.

The project is a joint venture between Platinum Group; integrated PGM producer Impala Platinum Holdings Ltd. (OTCQX: IMPUY); Japanese consortium HJ Platinum, which includes trading house Hanwa Co. and the government-backed Japan Organization for Metals and Energy Security (JOGMEC); and local empowerment partner Mnombo Wethu Consultants (Pty) Ltd. Platinum Group has an effective 50.22% interest in the Waterberg Project.

The company’s primary business objective is to advance the Waterberg Project to a development and construction decision. An update to the 2019 Definite Feasibility Study is expected in 2024.

PGMs are essential and precious metals that include platinum, palladium, rhodium, iridium, osmium and ruthenium. These metals are known for their purity, high melting points and unique catalytic properties. They are utilized in a number of industrial processes, technologies and commercial applications and play a critical role in autocatalysis and pollution control in the automotive sector. The bulk of global PGMs are mined in Southern Africa and Russia.

The unique properties of PGMs are being applied to various technologies as possible solutions for more efficient energy generation and storage, which may create new demand for PGMs. The company’s battery technology initiative through Lion Battery Technologies Inc., using platinum and palladium in lithium battery technologies, represents one such new opportunity in the high-profile lithium battery research and innovation field.

Platinum Group Metals Ltd. founded Lion Battery Technologies Inc. in partnership with Anglo American Platinum Ltd. (AMS: JNB) to support the use of palladium and platinum in lithium battery applications. Lion Battery has entered into an agreement with Florida International University to further advance a research program that uses platinum and palladium to unlock the potential of Lithium Sulfur (Li-S) battery chemistries.

Platinum Group is headquartered in Vancouver, B.C., and Johannesburg, South Africa.

Waterberg Project

Platinum Group’s sole material mineral property, the Waterberg Project, is presently in process with pre-construction permitting; engineering work, including road upgrade and traffic studies; finalization of power and water infrastructure design; and construction camp design.

The company’s principal product from the Waterberg Project is planned to be a PGM-bearing concentrate. The concentrate will contain economic amounts of six elements comprising platinum, palladium, rhodium, gold, copper and nickel. The company’s partner in the Waterberg Project, Impala Platinum Holdings, has acquired a right of first refusal to enter into an offtake agreement, on commercial arm’s-length terms, for the smelting and refining of mineral products from the Waterberg Project.

The Waterberg project has proven and estimated reserves of 19.5 million ounces of PGMs and gold. When fully operational, the mine is projected to produce more than 400,000 ounces of PGMs annually during the peak period of steady state production. The life of the mine is projected at 45 years.

South Africa’s PGM mining sector remains closely tied to economic developments in the global automotive industry, which in 2022 accounted for approximately 43% of the total global demand for platinum and 82% of the total global demand for palladium.

Market Opportunity

According to a report from Straits Research, a global market and business research firm, the worldwide platinum market had an estimated value of $7.72 billion in 2022 and is projected to reach $11.95 billion by 2031. That represents a CAGR of 5.13% over the forecast period.

Platinum, one of the rarest of precious metals, is about 30 times scarcer than gold. It is crucial to the automotive and electronics industries and is also used to make jewelry. Stricter emissions regulations around the world have led to an increased demand for platinum to be used in catalytic converters to reduce automotive emission, the report states.

A report from Allied Market Research estimated the global palladium market at $16.3 billion in 2021 and projects the market will reach $28.6 billion by 2031, growing at a CAGR of 5.8% over the period.

Palladium is also used in automotive catalytic converters for reducing emissions and in jewelry, dentistry, watchmaking, blood sugar test strips, aircraft spark plugs, surgical instruments, electrical contacts and musical instruments.

An increase in demand for consumer electronics has driven demand for palladium-based multilayer ceramic capacitors (MLCC) used to store energy in electronic devices such as broadcasting equipment, mobile telephones, computers, electronic lighting and high voltage circuits, according to the report.

Management Team

Frank R. Hallam is Co-Founder, Director, President and CEO of Platinum Group. He has over 30 years of experience in the mining, minerals and petroleum industry as an operator, principal and founder. He was a co-founder and former CFO of MAG Silver Corp. He was also co-founder and director of West Timmins Mining Inc. and a director of Lake Shore Gold Corp. In addition, he was CFO and director with gold exploration company Tan Range Exploration Corp. He is a Chartered Professional Accountant and was formerly an auditor in the public mining practice of PwC. He holds a Bachelor of Business Administration from Simon Fraser University.

Greg Blair is CFO of Platinum Group. He has been with Platinum Group since 2010 in various roles, most recently as Interim CFO. Prior to joining Platinum Group, he was at a public accounting firm working on public company (mainly mining) audits. He is a Chartered Professional Accountant and holds a degree in Economics from Simon Fraser University and has completed the Canadian Securities Course.

Kris Begic is VP Corporate Development of Platinum Group. He has over 25 years of experience in the mining industry and capital markets and has been involved with the raising of over $500 million for various exploration and development projects globally. His efforts are focused on project generation, mergers and acquisitions, capital markets, investor relations and marketing.

Platinum Group Metals Ltd. (NYSE American: PLG), closed Thursday's trading session at $1.54, up 1.9868%, on 148,172 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $22.60/$.

Recent News

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF)

The QualityStocks Daily Newsletter would like to spotlight Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF).

AI Transforms Mining: AI speeds up mineral discovery by analyzing large datasets, predicting drill targets, and improving operational efficiency.

A McKinsey report estimates that AI could unlock $290 billion to $390 billion in annual savings for producers of key resources by 2035.

Emperor Metals' Advantage: At Duquesne West, Emperor Metals used AI and DomainMCF to develop a 3D geological model, accelerating discovery and unlocking new high-priority exploration targets.

As the global mining industry faces mounting pressures to boost productivity, reduce costs and minimize its environmental impact, artificial intelligence ("AI") is emerging as a necessary evolution. A 2022 McKinsey report estimates that AI could unlock $290 billion to $390 billion in annual savings for producers of key resources by 2035.

At the forefront of AI-driven exploration is Emperor Metals Inc. (CSE: AUOZ) (OTCQB: EMAUF) (FSE: 9NH), a junior mining firm based in Quebec. The company has integrated AI into its flagship Duquesne West Gold Project in Quebec's Abitibi Greenstone Belt, a prolific Canadian gold mining distinct currently hosting 15 producing gold mines.

Emperor Metals Inc. (CSE: AUOZ) (FRA:9NH) (OTCQB: EMAUF) is an advanced stage gold exploration company focused on proving and developing the substantial resource potential of its flagship Duquesne West Gold Project located in the Tier 1 district of the Southern Abitibi Greenstone belt of Rouyn-Noranda, Quebec. The Project has a 2011 historical mineral resource estimate of 727,000 ounces of Au at 5.42 g/t and an average thickness of 5.71 m*.

In 2023, with the use of AI (Artificial Intelligence), Emperor Metals created the first ever 3D mineralized and geological model, which illuminated the potential to add significant ounces to this deposit. Using these models, Emperor’s had a very successful 2023 drilling campaign of 8,579 m. In addition to laterally extending high grade zones by intercepting grades of 15.8 g/t Au over 10.8 meters, Emperor encountered intercepts of lower grade bulk tonnage in the host rocks (1.69 g/t Au over 25 m). This led to envisioning a different strategy of exploration and the revelation that a conceptual open-pit potentially overlies this high-grade gold deposit. Historic core sampling began (2,500 m) for discovering overlooked lower grade gold in the host rock around the high-grade lenses. Lower grade bulk tonnage gold improves the open-pit economics by reducing stripping ratios and adding overlooked incremental ounces for open pit mining.

Emperor Metals is set to begin a fully funded Phase II 8,000 m drilling program in May 2024. The company also plans on assaying an additional 8,000 m of historic core within the open pit model. Emperor is working toward producing an updated NI 43-101 Mineral Resource Estimate by Q1 2025.

The company is led by a dynamic group of resource sector professionals who have a strong record of success in evaluating and advancing mining projects from exploration through to production, attracting capital and overcoming adversity to deliver exceptional shareholder value.

Project

Emperor Metals has an option to earn 100% ownership of the Duquesne West Gold Project, a mineral claim package comprising 38 claims covering approximately 1,389 ha (3,432 acres) in Quebec.

The Duquesne West Gold Property is located 32 kilometers northwest of the city of Rouyn-Noranda and 10 kilometers east of the town of Duparquet. The property lies within the historic Duparquet gold mining camp in the southern portion of the Abitibi Greenstone Belt in the Superior Province.

Emperor is targeting the potential multimillion-ounce resource in a combination of conceptual open pit and underground mining scenarios. A Phase I drill campaign and historical core sampling program was completed in 2023, which included resource confirmation and exploration drilling, focusing on delineating and growing the resource toward development.

The property hosts a historical inferred mineral resource estimate of 727,000 ounces of gold at a grade of 5.42 grams per ton (g/t) and average stope thickness of 5.71 m. The mineral resource estimate predates modern Canadian Institute of Mining guidelines, and a Qualified Person on behalf of Emperor Metals has not reviewed or verified the mineral resource estimate. Therefore, it is considered historical in nature and is reported solely to provide an indication of the magnitude of mineralization that could be present on the property. The gold system remains open for resource identification and expansion.

Reinterpretation of the existing geological model was created using artificial intelligence and machine learning. This AI model shows the opportunity for additional discovery of ounces by revealing gold trends unknown to previous workers and the potential to expand the resource along significant gold-endowed structural zones. Multiple scenarios exist to expand additional resources, which include:

  • Underground High-Grade Gold
  • Open Pit Bulk Tonnage Gold
  • Underground Bulk Tonnage Gold

The Duquesne West-Ottoman property straddles the Porcupine-Destor gold localizing fault several kilometers east of the town of Duparquet. A number of previous drill campaigns have outlined an inferred resource of 4.17 million tons grading 5.42 g/t of gold (cut) or 6.36 g/t (uncut), as reported in the NI 43-101 report titled “Technical Report and Mineral Resource Estimate Update for the Duquesne-Ottoman Property, Quebec, Canada.”

Emperor Metals is funded for an 8,000-meter drilling program focusing primarily on adding ounces to the current resource within and lateral to the open pit model. An additional 8,000 m of historical core sampling and assaying is included in the budget to help build incremental ounces in the open-pit environment.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, to be worth nearly $5 trillion.

The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth. This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

In May 2024, the market price of gold was approximately $2,340 per ounce.

Management Team

John Florek, P.Geol., is President, CEO and Director of Emperor Metals. He has more than 35 years of technical and senior management experience with major and junior mining companies, including roles as founder, vice president and director. He has helped identify and develop significant asset value for mines and exploration projects from grass roots through development. He has worked for several major mineral producers, including BHP, Placer Dome, Barrick, Teck and Detour Gold/Kirkland Lake Gold/Agnico Eagle.

Sean Mager is CFO and Director of Emperor Metals. He has worked more than 30 years in the mining sector, including extensive experience in corporate development, stakeholder relations, regulatory, financial and operations.

Alex Horsley is Head of Corporate Development and Director of Emperor Metals. He has more than 20 years of experience in the mining sector and capital markets with a focus on finance, marketing, management, corporate development and communications. He is founder and former CEO of Emperor Metals. He has assisted in raising more than C$40 million for exploration and development mining companies.

*Power-Fardy and Breede, 2011. The Mineral Resource Estimate (MRE) constructed in 2011 is considered historical in nature as it was constructed prior to the most recent Canadian Institute of Mining and Metallurgy (CIM) standards (2014) and guidelines (2019) for mineral resources. In addition, the economic factors used to demonstrate reasonable prospects of eventual economic extraction for the MRE have changed since 2011. A qualified person has not done sufficient work to consider the MRE as current. Emperor is not treating the historical MRE as current. The reader is cautioned not to treat it, or any part of it, as a current MRE.

Emperor Metals Inc. (OTCQB: EMAUF), closed Thursday's trading session at $0.0637, up 2.7419%, on 2,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.05715/$0.14505.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Following the enactment of emergency regulations to ban intoxicating hemp products in the state of California, players in the hemp industry filed a lawsuit against the state's Department of Public Health to overturn the rules. Now plaintiffs in the lawsuit are requesting a state judge to halt the enforcement of the regulations until a ruling is given by the courts on the matter. In their suit, the plaintiffs argue that the ban is unlawful and will cause irreversible damage to the nascent hemp industry. The new request argues that allowing the regulations to remain in effect would eliminate almost every ingestible hemp product currently being sold in the state, including the majority of nonintoxicating products. This means that many small businesses will have to halt their operations, which will result in losses worth millions of dollars. A hearing on the proposed temporary restraining order is set for later this week in Los Angeles. The plaintiffs include the U.S. Hemp Roundtable, Cheech and Chong's Global Holdings, Sunflora, Lucy to Be Beverage, Boldt Runners, Blaze Life and Juicetiva. This patchwork of regulations in different states gives businesses such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) more hurdles to navigate as they conduct their legal business activities. A suitable way out would be for the federal government to come up with comprehensive regulations for cannabinoids so that interested parties can have one law to refer to when conducting their operations.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Thursday's trading session at $0.026, up 8.3333%, on 47,332 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

Alcohol detection and monitoring devices have been in use for years, but the need for faster, discreet technology capable of delivering real-time results became more apparent in the mid-2010s

In 2015 and 2016, the NIAAA announced challenges seeking alcohol monitoring solutions that provide real-time results; the winning entries were wearable wristbands still at the prototype stage

Fast-forward to today, and SOBRsafe, a company providing next-generation alcohol detection technology, commercializes its market-validated SOBRcheck(TM) stationary alcohol screening device and the SOBRsure(TM) wearable wristband

SOBRsafe's devices feature highly precise sensors that are calibrated for early, low alcohol detection, beginning at about 20 minutes, compared to 45-60 minutes for the leading mandatory ankle monitor

The company believes its disruptive breakthrough technology could become the global standard for alcohol monitoring and detection, replacing legacy products and testing methods

In 2015 and 2016, the National Institute on Alcohol Abuse and Alcoholism ("NIAAA"), a part of the National Institutes of Health ("NIH"), challenged innovators and entrepreneurs to create a "wearable or otherwise discreet device capable of measuring blood alcohol level in real-time." The challenge aimed to help solve the disadvantages of the then-preferred technologies for alcohol monitoring. "Current technology for continuous alcohol monitoring takes a reading every 30 minutes. We are seeking a solution that improves on this interval and most closely approximates real-time monitoring and data collection," stated the circular from NIAAA explaining the rationale behind the 2015 challenge (https://ibn.fm/EhUO8). The winners designed wearable wrist monitors that measure transdermal alcohol concentrations ("TAC") (https://ibn.fm/fpXye). While these winning entries were prototypes, the competition perhaps inspired the modern alcohol detection and monitoring landscape. Today, there are validated, commercially available transdermal alcohol monitoring devices available on the market, some more capable than others. One company in particular, SOBRsafe (NASDAQ: SOBR), commercializes its SOBRcheck(TM) stationary screening and SOBRsure(TM) wearable monitoring solutions, which utilize a proprietary transdermal technology that simplifies the alcohol detection process. According to the company, the SOBRsafe transdermal detection technology pairs a NIAAA-awarded transdermal gas sensor with proprietary algorithms to capture alcohol vapor excreted through skin pores alongside other contents of sweat.

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Thursday's trading session at $6.89, off by 4.4383%, on 114,301 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.70/$110.00.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Proceeds from the offerings will support the company's operations into the first quarter of 2025.

Clene also amended its existing debt facility with Avenue Venture Opportunities Fund, L.P. to reduce or defer future monthly principal payments and to extend principal amortization period and the final maturity date into the first half of 2025.

The company's lead drug candidate, CNM-Au8® has been shown to restore and protect neurological function, offering new hope for patients with ALS and other neurodegenerative conditions.

Clene is seeking an accelerated approval pathway for CNM-Au8 for ALS, with a meeting scheduled with the FDA before the end of November.

Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis ("ALS") multiple sclerosis ("MS") and Parkinson's Disease ("PD"), announced the successful closing of a $7.3 million registered direct offering and concurrent private placements, designed to boost its capital position during a crucial phase in its on-going operations.

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.

CNM-Au8

CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Thursday's trading session at $5.51, off by 5.812%, on 66,155 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.8181/$12.00.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company announced Thursday morning that it participated in a Virtual Investor KOL Connect segment. Members of the company's management team and Dr. Samuel Goldlust, who previously served as an investigator in the company's global potentially pivotal study of Berubicin, joined the segment to provide a corporate update, discuss the unmet need in glioblastoma multiforme ("GBM"), and highlight the opportunity for the company.

To access the segment, visit https://ibn.fm/V1eC1

To view the full press release, visit https://ibn.fm/rAdeF

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Thursday's trading session at $0.1174, off by 4.1633%, on 1,182,663 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0955/$6875.00.

Recent News

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF)

The QualityStocks Daily Newsletter would like to spotlightFathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF).

Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF), an exploration company targeting magmatic nickel sulphide discoveries to support the rapidly growing global electric vehicle market, will be participating at the upcoming Red Cloud Fall Mining Showcase. The in-person event is scheduled for Oct. 16–17, 2024, in Toronto. According to the company, Fathom Nickel's CEO and VP of exploration Ian Fraser will be presenting during the annual conference; Fraser's presentation is scheduled to begin at 10 a.m. EST on Oct. 17.

To register or learn more about the event, visit https://ibn.fm/SPKEZ

To view the full press release, visit https://ibn.fm/Yo1yM

Fathom Nickel Inc. (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) is a Canadian natural resource development and exploration company that targets high-grade nickel sulfide discoveries for use in the rapidly growing global electric vehicle (EV) market. The company has a portfolio of two high-quality exploration projects located in the prolific Trans Hudson Corridor in Saskatchewan.

Led by a management team with more than 100 years of combined mining and exploration experience, Fathom believes in a continuing bright outlook for nickel and its increasing use in the manufacturing of batteries needed for energy storage in the high-growth renewable energy and EV industries. The company’s modern approach to exploration has yielded significant new nickel discoveries.

Fathom is headquartered in Calgary, Alberta.

Projects

The Albert Lake Project

The Albert Lake Project comprises 90,460 hectares of lands located in north-central Saskatchewan, with over 80,000 hectares currently unexplored. The project is host to the historic Rottenstone Mine, a high-grade, open pit nickel sulfide past producer that was active from 1965 to 1969 and yielded ~26,000 tonnes of 3.3% Ni, 1.8% Cu, and >9 g/t Pd-Pt+Au.

The geological setting of the Albert Lake Project is within the Trans Hudson Orogeny (Corridor), which is host to numerous world-class nickel mining camps including the Thompson Nickel Belt (currently operating with more than 5 billion pounds of nickel produced since 1959), Lynn Lake (past producer) and Raglan Nickel Belt (currently operating with more than 39,000 tons of nickel produced in 2020).

The project is fully permitted. Exploration plans for 2024 include drilling a high-priority target located approximately 2km south of the historic Rottenstone Mine along with drilling other high-priority targets. Additional soil geochemistry, surface geophysical programs and geological mapping and prospecting will be performed during the summer field season.

The Gochager Lake Project

The Gochager Lake Project in northern Saskatchewan, also in the prolific Trans Hudson Corridor, was recently expanded through the addition of the contiguous Watt’s Lake property and direct staking, bringing its total land area to 22,620 hectares.

The Gochager Lake property is host to a historic resource defined by drilling in 1966-1967 consisting of 4.2 M tons grading 0.29% Ni and 0.08% Cu. Recent drilling by Fathom has defined multiple very robust off-hole borehole electromagnetic (BHEM) responses in eight of nine holes drilled in 2023 and three historic drill holes probed. There is very strong evidence of multiple, high-grade nickel-copper-cobalt steeply oriented chutes within the historic Gochager Lake Deposit.

Prior to Fathom exploration in 2023 and since 1970, exploration at the property has been limited to small drill programs in 1989-1990 and 2018. Exploration plans for 2024 include expanded surface geophysical programs, drilling and continued BHEM surveys to expand tons and increase the grade of the historic Gochager Lake deposit. Summer exploration will consist of soil geochemistry, mapping, prospecting and additional surface geophysical programs focused on identifying other Gochager-like deposits within the current land package.

Market Opportunity

Nickel plays a crucial role in clean energy technologies, and that is expected to cause demand to well outstrip supply for the foreseeable future.

With an annual market value of around $35 billion, nickel demand is projected to rise due to its intensive use in lithium-ion batteries used to power EVs. However, new discoveries of nickel sulfide deposits (currently the most reliable source for battery-grade class 1 nickel) have been rare, which could constrain class 1 nickel supply in the coming years.

According to Deloitte’s global EV forecast, total EV sales will grow from 2.5 million in 2020 to 11.2 million in 2025, reaching 31.1 million by 2030 and representing approximately 32% of the total market share for new car sales. Over the next 10 years, the EV market is projected to see a CAGR of 29%, with increased demand for nickel expected to be comparable.

Management Team

Fathom Nickel has assembled a best-in-class leadership team consisting of highly qualified industry professionals with deep knowledge and understanding of the mineral exploration industry and capital markets.

Ian Fraser, P.Geo., is CEO, VP Exploration and Co-Founder of Fathom Nickel. He has more than 35 years of experience in mineral exploration, as well as managing and implementing exploration projects in Canada and internationally. His experience includes resource interpretation and development of the Casa Berardi Gold Mine and Komis Gold Mine, as well as the Cisneros Gold Mine in Colombia.

Doug Porter, CPA, CA, CBV, is President, CFO and Director of Fathom Nickel. He is a senior financial and accounting executive with specific emphasis in resource company management. His career includes positions with Elan Coal Ltd., Altitude Resources Ltd. and StimWrx Oilfield Services Ltd.

Fathom Nickel Inc. (OTCQB: FNICF), closed Thursday's trading session at $0.026405, off by 2.2037%, on 10,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.013465/$0.17.

Recent News

Dynasty Gold Corp. (TSX.V: DYG) (OTC: DGDCF)

The QualityStocks Daily Newsletter would like to spotlight Dynasty Gold Corp. (TSX.V: DYG) (OTC: DGDCF).

Dynasty Gold (TSX.V: DYG) (FSE: D5G1) (OTC: DGDCF), a Canadian mineral exploration company, today announced results from its 2024 annual general meeting held on October 4, 2024. The company reported that all resolutions were approved and that Ivy Chong, Roman Shklanka, Larry Kornze, and Richard Redfern were elected directors until the next annual general meeting. The company also provided an update on the drilling progress at its Thundercloud Project, capturing the results from the three drilling campaigns conducted between 2022 and 2024. "This project looks very promising of becoming a mine, given these grades and shallow intercepts," said Roman Shklanka, Ph.D. (Geology), Director.

The company expects to soon receive more results from the recently completed drill program. Dynasty also reported that an exploratory drill program in the West Contact zone, which aims to further test the currently obtained trench assay of 8.04 g/t over 39 meters, was underway. According to the announcement, Dynasty maintains a solid financial position with no debt and about 61 million shares issued and outstanding.

To view the full press release, visit https://ibn.fm/3UEfc

About Dynasty Gold Corp.

Dynasty Gold Corp. (TSX.V: DYG) (OTC: DGDCF) is rapidly emerging as a notable player in the gold sector. With its impressive portfolio of high-potential projects and recent drilling results, Dynasty Gold is capturing the attention of investors and industry analysts alike. As the company continues to advance its exploration efforts, the potential for substantial gains becomes increasingly evident.

Many respected analysts agree that gold is in the early stages of a new commodities supercycle, where multiple forces like inflation, infrastructure spending, and global demand are driving the price surge. The question is, ‘how to profit from it’.

Dynasty Gold’s recent drilling campaign at its flagship Thundercloud project in Ontario, Canada, has delivered results that are likely to reshape expectations and could significantly impact the company’s fortunes. The latest drilling assays from the project reveal high-grade gold mineralization, confirming the project’s potential for substantial resource development.

With high-quality North American assets, renowned leadership and a miniscule market cap, Dynasty Gold looks perfectly positioned to capitalize on any potential updraft in prices and potentially deliver outsized returns. In fact, if the next batch of drill holes (expected within weeks) is successful in expanding the economics of the resource, DYG could easily outperform the market and lead the pack to the upside.

There are only about 61 million Dynasty shares issued and outstanding, with roughly 40% owned by insiders and long-term shareholders. It’s important to note that Rob McEwen owns 9.7%. A mining legend, McEwen founded Goldcorp and increased the company’s market cap 160X – from $50M to over $8B. He must see value in Dynasty Gold, too. Around 50% of outstanding shares are held by retail investors, and any positive news on top of surging global demand could catapult the stock.

High-Grade Deposits, 100% Owned

The Thundercloud Property

The Thundercloud property is situated in the prolific Archean Manitou-Stormy Lakes greenstone belt in Western Ontario, which has a geological setting similar to the Abitibi belt but is much less thoroughly explored. The region contains numerous gold showings, along with several deposits and historic producers. Initial results suggest excellent potential for bulk-tonnage orogenic gold mineralization, with the possibility of high-grade mineralization. In recent years, nearly 30 million ounces of gold have been discovered in the area.

Dynasty Gold’s Thundercloud project is strategically located within one of Canada’s most prodigious gold-producing regions. Ontario is renowned for its rich mineral deposits and supportive mining infrastructure, providing a favorable environment for exploration and development. The Thundercloud property covers approximately 5,560 acres and is located 47 kilometers southeast of Dryden, Ontario. It is accessible via the Trans-Canada Highway (Hwy 17). Dryden, a resource-based town, offers essential infrastructure for mining operations.

Dynasty recently completed Phase 1 of its 2024 Drill Program at its Thundercloud property, announcing results in an August press release.

Ivy Chong, President and CEO, commented, “Dynasty completed Phase 1 of the 4,000 meters planned drilling, consisting of 11 holes for a total of 2,198 meters. The eight holes within the Pelham Zone all intersected intervals from 10+ to 70 meters of strong pyrite veinlets and disseminations similar to that associated with high-grade mineralization in the previous two years of grades up to 8.4 g/t gold over 73.5m including 151.7 g/t gold over 3.0m. We look forward to receiving the assay results from Phase 1 drilling within the next several weeks and will re-commence drilling in early September, once these results have been analyzed and an additional 10 or more drill holes sited.”

The recent drilling results at Thundercloud have substantial implications for the project’s future. High-grade gold intercepts are indicative of a robust mineralized system, which could lead to a significant increase in the project’s resource estimate. Despite this high-grade, the company’s drill holes are comparatively shallow (less than 250 meters in length). Many similar projects are required to drill as deep as 700+ meters to obtain grades similar to Dynasty’s recent results. This, in turn, enhances the project’s attractiveness to major mining companies and institutional investors.

The impressive drilling results from Dynasty’s Canadian project will be followed by more drilling with more news expected in the next few weeks. Roughly 90% of the project has thus far seen limited drilling and therefore represents untested potential. Positive assay results often generate increased interest and confidence as the market reacts to the potential for significant resource discoveries.

The Golden Repeat Property

Located on the north slope of the Midas Trough, along the Carlin Trend within the Northern Nevada Rift, the Golden Repeat gold property comprises 49 contiguous mining claims totaling approximately 968 acres. These claims share geological similarities with gold properties in the well-known Midas Gold Camp.

Hecla Mining Company’s Midas Mine is located 18 kilometers east of the property, with other major Carlin-style gold mines, including Nevada Gold Ventures LLC’s Getchell-Twin Creeks-Turquoise Ridge mines (15 kilometers southwest) and its Goldstrike Mine complex (50 kilometers southeast) nearby.

The property is easily accessible from Interstate 80, with excellent local mining infrastructure. Gold Fields and Romarco Minerals briefly drilled the property in the 1990s, but a large portion remains unexplored.

Market Opportunity

In 2023, the World Gold Council estimated the physical financial gold market – comprising bars, coins, gold ETFs, and central bank reserves – was valued at nearly $5 trillion.

This historical scarcity and relatively slow rate of new production, compared to other commodities, are key reasons gold has retained its value for millennia. In September 2024, the spot price of gold was quoted at just over $2,497 per ounce.

Dynasty Gold’s strategic focus on expanding its resource base and advancing its exploration efforts positions it well for future success. The company’s ongoing drilling programs are designed to further delineate and expand the high-grade zones identified, which could lead to a substantial resource upgrade and increased project valuation.

Additionally, the potential for resource expansion and the attractiveness of Dynasty Gold’s project in a top-tier mining jurisdiction such as Ontario could attract interest from strategic partners or acquisition targets. Options include both smaller scale high-grade production in the near term or bulk tonnage production in the years ahead. Such developments would provide additional opportunities for capital infusion and project acceleration, further supporting a positive trajectory for the stock price.

Management Team

Ivy Chong has served as CEO of Dynasty Gold since 2008. With over two decades of experience in the mining and oil & gas industries, she has negotiated several option and joint venture agreements with major companies such as Teck, AngloGold Ashanti, Azimut, and Avocet Mining. She has assisted numerous companies with IPOs and raised capital for resource firms across Asia, Europe, and North America. Before entering the resource industry, she worked at the Hong Kong Stock Exchange and Deloitte and Touche LLP.

Larry Kornze, VP of Exploration and Director at Dynasty Gold, brings over 30 years of international gold exploration experience to the company. He is credited with discovering Barrick’s 40-million-ounce gold deposit at the Betze Mine on the Carlin Trend in Nevada during the late 1980s. Kornze was also involved in the discovery of other significant deposits in Nevada, including Miekle, Deepstar, Screamer, and Rodeo. He has held positions with Newmont and Getty Mining in North America and serves on the boards of several public gold exploration companies.

Dynasty Gold Corp. (OTC: DGDCF), closed Thursday's trading session at $0.089, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.077/$0.1893.

Recent News

Freight Technologies Inc. (NASDAQ: FRGT)

The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).

Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.

Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.

The Fr8Tech Solutions Suite

Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:

  • Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
  • Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
  • Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
  • Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
  • Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
  • Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

Commitment to the Environment

Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.

Fr8University

Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.

Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.

Market Outlook

Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.

Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.

Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.

Management Team

Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.

Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).

Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.

Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.

Freight Technologies Inc. (NASDAQ: FRGT), closed Thursday's trading session at $1.97, up 14.5349%, on 269,767 volume. The average volume for the last 3 months is 491,273 and the stock's 52-week low/high is $1.45/$350.00.

Recent News

PaxMedica Inc. (NASDAQ: PXMD)

The QualityStocks Daily Newsletter would like to spotlight PaxMedica Inc. (NASDAQ: PXMD).

PaxMedica Inc. (NASDAQ: PXMD) is a clinical stage biopharmaceutical company focusing on the development of novel anti-purinergic therapies (APTs) for the treatment of Autism Spectrum Disorder (ASD) and other serious conditions with intractable neurologic symptoms.

The company’s lead programs are focused on ASD, for which there are currently no approved pharmacologic treatments that target its cause and symptoms. Currently used treatments only address the symptoms of the condition, rather than targeting the pathophysiology itself.

PaxMedica is on a promising path to address these unmet medical needs, bringing hope to millions. Anti-purinergic therapies target the excess production of purines in cells. An overexpression of purines can offset homeostasis and result in an overproduction of cellular adenosine triphosphate, the main energy molecule in all living cells.

The company is headquartered in Tarrytown, New York.

Product Pipeline

PaxMedica is building a robust pipeline of products targeting ASD and related neurodevelopmental conditions. The company’s lead product in development may help eliminate, reduce or modulate some of the more troublesome aspects of ASD. That would open the potential for people with autism to integrate their behavior with others more successfully and improve their lives.

PaxMedica’s lead programs, PAX-101 and PAX-102, utilize the company’s proprietary source of suramin sodium, a broadly acting anti-purinergic therapy that has been known for over 100 years. Its current pipeline includes:

  • PAX-101 (IV Suramin) for ASD – PAX-101 completed a Phase 2B study for ASD in 2021. Suramin is a broadly acting APT and has reported positive results from a dose range study. The results of PaxMedica’s Phase 2B study, which targeted 52 subjects across six sites in South Africa, were presented to AACAP in October 2021.
  • PAX-102 (Intranasal Suramin) – PaxMedica has developed a proprietary intranasal formulation of suramin that is currently being evaluated in ASD and other neurodevelopmental conditions.
  • PAX-101 for HAT – Given suramin’s historical use as a treatment for Human African Trypanosomiasis (HAT), or African Sleeping Sickness, the company is also developing PAX-101 as a treatment for HAT. PaxMedica’s most advanced program is the pursuit of PAX-101 for early-stage East African HAT.
  • Selective APTs – PaxMedica has conducted several preclinical studies to evaluate other APTs that are more selective to specific purinergic receptors and may offer additional benefits over suramin.

Market Opportunity

According to a report by Fortune Business Insights, a leading global market research company, the global ASD therapeutics market was estimated at $1.93 billion in 2022 and is projected to grow from $2.01 billion in 2023 to $3.42 billion by 2030, a CAGR of 7.9% over the forecast period. As there is no current treatment for the core symptoms of autism, PaxMedica believes the addressable market for PAX-101, if approved, could greatly exceed these forecasts.

Autistic disorder, Asperger’s Syndrome and Pervasive Development Disorder are the three main types of ASD, affecting millions of people globally. A 2020 report by the U.S. Centers for Disease Control & Prevention estimated that one in 36 children in the U.S. have been diagnosed with autism disorder.

Several factors are expected to contribute to market growth prospects. A growing prevalence of the condition globally and rising awareness coupled with available treatment options are key factors expected to drive ASD therapeutics market growth during the forecast period. Growing investment in R&D to find effective treatments is also expected to fuel global market growth.

Management Team

Howard Weisman is Chairman and CEO of PaxMedica. He has been a founder and CEO of several specialty pharma and medical device companies. Most recently, he was executive chairman and co-founder of Sofregen, a biotech company. He also served as CEO and president of Seventh Sense Biosystems, a medical device development company. He also was founder, chairman and CEO of EKR Therapeutics, a specialty pharmaceutical company, and founder and COO of ESP Pharma, a company focused on cardio and neurovascular products. He has a bachelor’s degree in chemistry from Rutgers University.

David Hough, M.D., is Chief Medical Officer at PaxMedica. He is a neuroscience clinical development consultant who previously served as vice president at Janssen Research and Development and in various leadership roles over 17 years. Most recently, he was the compound development team leader for SPRAVATO® for treatment-resistant depression. Prior to that, he was the schizophrenia disease area leader. He played a pivotal role in the development programs for oral INVEGA®, INVEGA SUSTENNA® and XEPLION® for schizophrenia. He is a graduate of West Point and is board certified in psychiatry.

Stephen Sheldon is COO and CFO at PaxMedica. He has served as CEO of Thailand-based specialty healthcare company Indochina Healthcare Co. Ltd. since 2015. Previously, he was a consultant for PricewaterhouseCoopers Healthcare Advisory in the Chicago office. He was responsible for developing specialty pharmacy patient programs, strategy development for specialty products and compliance programs. He has an MBA from Thunderbird School of Global Management and a bachelor’s degree in computer science and visual arts from Bowdoin College.

PaxMedica Inc. (NASDAQ: PXMD), closed Thursday's trading session at $0.1299, up 12.9565%, on 43,203 volume. The average volume for the last 3 months is 74,462 and the stock's 52-week low/high is $0.061/$10.26.

Recent News

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF)

The QualityStocks Daily Newsletter would like to spotlight Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF).

Annovis Bio Inc. Overview

Renforth Resources Inc. (CSE: RFR) (OTCQB: RFHRF) is an active mineral exploration company engaged in the exploration and development of the company’s wholly owned multi-commodity mineral properties in Canada. The company owns the Parbec gold deposit on the Cadillac Break in Quebec and is currently exploring the Parbec property to increase the gold resource and identify a location to strip and bulk sample from surface.

In addition, the company holds the Nixon Bartleman gold property in Ontario and is also engaged in developing its wholly owned Malartic Metals Package, Quebec’s newest polymetallic battery minerals district with several areas of mineralization, one of which is the nickel, cobalt, copper and zinc mineralized Victoria structure boasting approximately 20 kilometers of strike with surface mineralization, limited drilling, road access and hydroelectric power.

Renforth is well positioned in the heart of the Abitibi Greenstone belt, which straddles the Canadian Provinces of Ontario and Quebec, on both of the Cadillac-Larder Lake and Destor-Porcupine faults – the two main structures responsible for a belt endowed with more than 300 million ounces of gold (including production, M&I reserves and resources to date), making it one of the world’s most prospective gold regions.

The Canadian Malartic Mine, one of Canada’s largest gold mines, is adjacent to each of Renforth’s brownfield Malartic area properties, the Parbec open pit gold resource and the Malartic Metals Package, which, in addition to several known battery metals mineralized structures, also hosts gold within the Pontiac sediments, a very under-explored geological setting.

The company is headquartered in Pickering, Ontario.

Projects

Parbec Gold Deposit

Renforth’s 100% owned Parbec Gold Deposit contains a gold resource designed with an open pit to capitalize on Parbec’s surface mineralization. An MRE on the project, effective December 2019 and now considered by Renforth to be obsolete, is based upon approximately 28,000 meters of drilling which occurred between 2007 and 2019.

Renforth drilled 15,000 meters of new holes in 2020 and 2021 which were not included in the MRE, but which did extend the mineralization deeper within the MRE. The 2020-21 drilling is considered to have validated an additional 13,000 meters of historic drilling from 1986-93.

The validation occurs as 10% of the historic holes were redrilled, with results comparable to the historic results in terms of geology and gold values. Any future MRE calculated at Parbec will benefit from the inclusion of the new and historic drilling.

In addition to this, Renforth’s current structural interpretation on the location of, and controls on, the gold mineralization at Parbec is materially different than the geological model for the outdated MRE. For the first time, Renforth has mapped the Pontiac contact and interpreted a hinge fold interacting with the Cadillac Break and allowing the movement of gold enriched fluids, with mineralization plunging to the south, into the Pontiac.

It is worth noting that a structural control on the adjacent, and much larger, Canadian Malartic Mine is the Sladen Fault transiting into the Pontiac. Currently, Renforth is testing this interpretation with a soil survey designed to outline an area for stripping and bulk sampling within the Pontiac south of the Cadillac Break.

Malartic Metals Package

Renforth’s wholly owned approximately 300-square-kilometer Malartic Metals Package in Quebec’s mining heartland includes surface mineralization of battery metals nickel, cobalt, copper, zinc and silver in separate structures, as well as a copper/silver discovery and gold mineralization. Lithium is also present in anomalous amounts in the sediments, though the source has not yet been located.

The property was assembled commencing in 2020 by adding claims to Renforth’s existing Malartic West property by map staking. The goal was to acquire historic gold and base metal showings, as well as pronounced magnetic anomalies, joining several of the areas of discrete historic exploration into a district scale property with several areas of interest for battery metals and a greenfield copper/silver discovery. The property benefits from its location in an established mining community, roads on the property, rail just off the property and hydroelectric power lines crossing the property, making logistics simple and the cost to operate quite low.

This is the first time this property has been assembled as it is today and actively explored. A significant portion of the property has never been explored.

Market Overview

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council. In August 2024, the market price of gold was approximately $2,435 per ounce.

Management Team

Nicole Brewster is President and CEO of Renforth Resources. During her tenure she has reconstituted the company, developed a maiden mineral resource and sold a gold deposit. She is a native of the Toronto area and has been around the mining business nearly all her life, having been raised by a successful mineral exploration geologist who worked (and is still working) around the world as an entrepreneur and geoscientist.

Ms. Brewster worked summer jobs in various segments of the mining business, which led to her employment as a contractor working in the early days of the digitization of exploration data, 3D modeling and data visualization. After working in the capital markets for a time, she returned to the mineral exploration business as a partner in a successful private firm with several employees.

Renforth Resources Inc. (OTCQB: RFHRF), closed Thursday's trading session at $0.0138, even for the day. The average volume for the last 3 months is 19,485 and the stock's 52-week low/high is $0.0068/$0.0242.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.